1.Expression of β-catenin and HNF-1α and their influence on prognosis in human hepatocellular carcinoma.
Chinese Journal of Oncology 2014;36(8):587-591
OBJECTIVETo study the expressions of β-catenin in hepatocellular carcinoma (HCC) tissue, adjacent cirrhotic liver tissue and hemangioma-surrounding liver tissue to understand whether their difference in expression will influence on the prognosis and to study the relationship between Wnt/β-catenin signaling pathway and HNF-1α expression.
METHODS50 specimens of HCC, 50 specimens of adjacent cirrhotic liver tissue and 7 specimens of hemangioma-surrounding liver tissue were used to detect the differences in the expression of β-catenin and HNF-1α in them by immunohistochemistry.
RESULTSThe expression rate of β-catenin was 74.0% (37/50) in the HCC tissue, 18.0% (9/50) in cirrhotic liver tissue, and 14.3% (1/7) in hemangioma-surrounding liver tissue. The expression rate of β-catenin in HCC tissue was significantly higher than that in the hemangioma-surrounding liver tissue (P = 0.002) and cirrhotic liver tissue (P < 0.001). The patients with abnormal expression had worse prognosis. Among the 50 HCC cases, the expression of HNF-1α was negative in 20.0% (10/50), weak positive in 40.0% (20/50), moderately positive in 26.0% (13/50), and strong positive in 14.0% (7/50). Among the 50 adjacent cirrhotic liver tissues, the expression of HNF-1α was negative in 12.0% (6/50), weak positive in 20.0% (10/50), moderately positive in 52.0% (26/50) and strong positive in 16.0% (8/50). In the 7 cases of hemangioma-surrounding liver tissue, the expression of HNF-1α was negative in 0(0/7), weak positive in 14.3% (1/7), moderately positive in 28.6% (2/7) and strong positive in 57.1% (4/7). The positive expression rate of HNF-1α in the HCC tissue was significantly lower than that in the hemangioma-surrounding liver tissues (P = 0.029) and adjacent cirrhotic liver tissues (P = 0.008). The patients with positive HNF-1α expression had a better prognosis. The abnormal expression of β-catenin was negatively correlated with positive HNF-1α expression (r = -0.673, P < 0.001).
CONCLUSIONSThe occurrence and development of HCC is related to the abnormal β-catenin expression. There is a negative correlation between Wnt/β-catenin signaling pathway and HNF-1α expression.
Carcinoma, Hepatocellular ; diagnosis ; metabolism ; Hemangioma ; Hepatocyte Nuclear Factor 1-alpha ; genetics ; metabolism ; Humans ; Immunohistochemistry ; Liver Neoplasms ; diagnosis ; metabolism ; Prognosis ; beta Catenin ; genetics ; metabolism
2.Glomerulocystic kidney disease: report of a case.
Yan ZHU ; Jing ZHAO ; Guang YU ; Yong-wei YU
Chinese Journal of Pathology 2011;40(7):488-489
3.Clinical phenotype and genetic analysis of three pedigrees with 17q12 microdeletion syndrome.
Qinghua WU ; Saisai YANG ; Can WANG ; Huirong SHI ; Xiangdong KONG ; Shumin REN ; Zhihui JIAO ; Ning LIU ; Panlai SHI
Chinese Journal of Medical Genetics 2020;37(4):397-400
OBJECTIVE:
To explore the genetic etiology of three pedigrees with a gestational history of fetal renal anomalies.
METHODS:
Peripheral venous blood or skin samples were derived from the probands of the three pedigrees. Copy number variation sequencing (CNV-seq) was applied to detect alterations of genome CNVs.
RESULTS:
The patient from pedigree 1 and the fetuses from pedigrees 2 and 3 all carried a heterozygous 17q12 deletion, with the size ranging from 1.4 Mb to 1.48 Mb encompassing the HNF1B gene.
CONCLUSION
The diagnosis of 17q12 microdeletion may be difficult during fetal period for its variable phenotypes. Alterations of chromosomal copy numbers need to be excluded in such patients.
Chromosome Deletion
;
Chromosomes, Human, Pair 17
;
genetics
;
DNA Copy Number Variations
;
Fetus
;
Genetic Testing
;
Hepatocyte Nuclear Factor 1-beta
;
genetics
;
Humans
;
Pedigree
;
Phenotype
4.Analysis of HNF1B gene variant in a fetus featuring infantile polycystic kidney disease.
Yan ZHANG ; Lina ZENG ; Li LIN ; Xian DONG
Chinese Journal of Medical Genetics 2022;39(2):205-208
OBJECTIVE:
To explore the genetic basis for a fetus featuring infantile polycystic kidney disease (IPKD).
METHODS:
Following elective abortion, fetal tissue and peripheral blood samples of its parents were collected for the extraction of genomic DNA. Whole exome sequencing was carried out to detect potential variants correlated with the phenotype.
RESULTS:
The fetus was found to harbor a heterozygous c.1370C>T (p.P457L) variant of the HNF1B gene, which was unreported previously. The same variant was not detected in either parent.
CONCLUSION
The heterozygous c.1370C>T (p.P457L) variant of the HNF1B gene probably underlay the IPKD in this fetus. Above finding has enabled genetic counseling and prenatal diagnosis for the family.
Female
;
Fetus
;
Hepatocyte Nuclear Factor 1-beta/genetics*
;
Humans
;
Mutation
;
Phenotype
;
Polycystic Kidney, Autosomal Recessive
;
Pregnancy
;
Prenatal Diagnosis
;
Whole Exome Sequencing
5.Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.
Massimo RONCALLI ; Amedeo SCIARRA ; Luca Di TOMMASO
Clinical and Molecular Hepatology 2016;22(2):199-211
Owing to the progress of imaging techniques, benign hepatocellular nodules are increasingly discovered in the clinical practice. This group of lesions mostly arises in the context of a putatively normal healthy liver and includes either pseudotumoral and tumoral nodules. Focal nodular hyperplasia and hepatocellular adenoma are prototypical examples of these two categories of nodules. In this review we aim to report the main pathological criteria of differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma, which mainly rests upon morphological and phenotypical features. We also emphasize that for a correct diagnosis the clinical context such as sex, age, assumption of oral contraceptives, associated metabolic or vascular disturbances is of paramount importance. While focal nodular hyperplasia is a single entity epidemiologically more frequent than adenoma, the latter is representative of a more heterogeneous group which has been recently and extensively characterized from a clinical, morphological, phenotypical and molecular profile. The use of the liver biopsy in addition to imaging and the clinical context are important diagnostic tools of these lesions. In this review we will survey their systematic pathobiology and propose a diagnostic algorithm helpful to increase the diagnostic accuracy of not dedicated liver pathologists. The differential diagnosis between so-called typical and atypical adenoma and well differentiated hepatocellular carcinoma will also be discussed.
Adenoma/*diagnosis/surgery
;
Carcinoma, Hepatocellular/diagnosis
;
Diagnosis, Differential
;
Focal Nodular Hyperplasia/*diagnosis/surgery
;
Hepatocyte Nuclear Factor 1-alpha/metabolism
;
Humans
;
Liver/pathology
;
Liver Neoplasms/*diagnosis/surgery
;
beta Catenin/genetics/metabolism
6.Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.
Massimo RONCALLI ; Amedeo SCIARRA ; Luca Di TOMMASO
Clinical and Molecular Hepatology 2016;22(2):199-211
Owing to the progress of imaging techniques, benign hepatocellular nodules are increasingly discovered in the clinical practice. This group of lesions mostly arises in the context of a putatively normal healthy liver and includes either pseudotumoral and tumoral nodules. Focal nodular hyperplasia and hepatocellular adenoma are prototypical examples of these two categories of nodules. In this review we aim to report the main pathological criteria of differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma, which mainly rests upon morphological and phenotypical features. We also emphasize that for a correct diagnosis the clinical context such as sex, age, assumption of oral contraceptives, associated metabolic or vascular disturbances is of paramount importance. While focal nodular hyperplasia is a single entity epidemiologically more frequent than adenoma, the latter is representative of a more heterogeneous group which has been recently and extensively characterized from a clinical, morphological, phenotypical and molecular profile. The use of the liver biopsy in addition to imaging and the clinical context are important diagnostic tools of these lesions. In this review we will survey their systematic pathobiology and propose a diagnostic algorithm helpful to increase the diagnostic accuracy of not dedicated liver pathologists. The differential diagnosis between so-called typical and atypical adenoma and well differentiated hepatocellular carcinoma will also be discussed.
Adenoma/*diagnosis/surgery
;
Carcinoma, Hepatocellular/diagnosis
;
Diagnosis, Differential
;
Focal Nodular Hyperplasia/*diagnosis/surgery
;
Hepatocyte Nuclear Factor 1-alpha/metabolism
;
Humans
;
Liver/pathology
;
Liver Neoplasms/*diagnosis/surgery
;
beta Catenin/genetics/metabolism